A5082391926- Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Diagnosis and treatment of tuberculosis
- Glioma Diagnosis and Treatment
- Nosocomial Infections in ICU
- Airway Management and Intubation Techniques
- COVID-19 Clinical Research Studies
- Venous Thromboembolism Diagnosis and Management
- Blood groups and transfusion
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Immune Cell Function and Interaction
- Platelet Disorders and Treatments
- Pancreatitis Pathology and Treatment
- Viral-associated cancers and disorders
- Respiratory Support and Mechanisms
- Amoebic Infections and Treatments
Chang Gung Memorial Hospital
2023-2025
Kaohsiung Chang Gung Memorial Hospital
2023
Linkou Chang Gung Memorial Hospital
2020-2023
Chang Gung University
2020
Background Plasma Epstein-Barr virus (EBV) DNA levels predict the prognosis of extranodal NK/T-cell lymphoma, nasal type (NK/TCL), but its role in other peripheral T-cell lymphomas (PTCL) remains undetermined. This study aimed to determine prognostic impact plasma EBV PTCL patients.
<b><i>Introduction:</i></b> Splenectomy is an important and potentially curative treatment for immune thrombocytopenia (ITP). Laparoscopic splenectomy (LS) has replaced open (OS) as the standard approach. The prognostic role of platelet count clinical indication preoperative transfusion are not entirely clear. <b><i>Methods:</i></b> We designed a study to explore impact surgical methods, count, in large, single-institute, long-term cohort ITP...
Topic: 30. Infections in hematology (incl. supportive care/therapy) Background: Patients with hematological diseases (HD) have lower antibody responses to vaccination, a higher risk of SARS-CoV-2 breakthrough, severe infection, and increased mortality during infection. Aims: We aim present the clinical features, outcomes, factors HD patients infection Taiwan period when monoclonal antibodies, antiviral agents were available at multiple medical centers. Methods: Adult who tested positive for...
To explore prognostic factors and outcomes of primary central nervous system lymphoma (PCNSL) diffuse large B-cell (DLBCL) in Taiwan, 124 PCNSL-DLBCL patients (from 1995 to 2021) were retrospectively analyzed. Mainly, two treatment modalities including sandwich chemoradiotherapy modified MATRix regimen employed these patients. Overall survival (OS) was determined by log-rank test time-dependent Cox analysis. Median OS all 27.1 months. 47 (37.9%) who underwent had a complete remission (CR)...